Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates 2018-06-23
  2. Diverse molecular targets for therapeutic strategies in Alzheimer's disease 2014-07-11

Studies

2 studies carry this tag.

Date range

2014 to 2018

Top journals

  • Alzheimer's research & therapy 1
  • Journal of Korean medical science 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Alzheimer's research & therapy 2018-06-23 Drug development

    Using a transcription factor-centered regulatory network reconstruction we were able to identify several potential molecular targets and six drug candidates for repositioning in AD.

  2. Diverse molecular targets for therapeutic strategies in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Journal of Korean medical science 2014-07-11 Drug development

    Alzheimer's disease (AD) is the most common form of dementia caused by neurodegenerative process and is tightly related to amyloid β (Aβ) and neurofibrillary tangles.

All topic tags with their study counts